Cimon Medical is the innovator and owner of a groundbreaking patent for continuous monitoring of blood-flow, using Doppler ultrasound technology.
The scalability of our technology enables the development of multiple products in various areas of medicine, where early and accurate recognition of ongoing blood flow disturbances can be the key to preventing damage. This in turn can improve treatment strategies and reduce social health costs, with the potential to develop new standards of care.
Using our technology in clinical research has made it clear that high quality blood flow velocity measurements within a region can be obtained with simpler equipment than previously available.
This circumvents the problem that has stumped previous attempts at continuous blood flow monitoring: attempting to establish an absolute measure in a single blood vessel.
Simple safety
NeoDoppler can play a decisive role in the assessment of cerebral perfusion
No need for specialized operators
The system can be handled by general health care professionals.
Non invasive
Does not require inserting of devices into the body.
Direct, continuous measurement
Instead of indirect or intermittent measurement of blood flow.
Flexible system
Well suited for integration with third-party systems.
Immediate response
Discovers changes in hemodynamics immediately, for fast intervention.
The scalability of our technology enables the development of multiple products in various areas of medicine, where early and accurate recognition of ongoing blood flow disturbances can be the key to preventing damage. This in turn can improve treatment strategies and reduce social health costs, with the potential to develop new standards of care.
Measurement of fetal wellbeing during delivery to support timely intervention decisions and avoid adverse events.
Measurement of brain blood-flow velocities in patients undergoing interventions or surgery.
Confirmation of reestablished blood-flow to the brain in emergency situations after cardiac arrest (during Cardiac Pulmonary Resuscitation).
Monitoring of peripheral circulation to support diagnosis of chronic arterial insufficiency and predict outcome of therapeutic interventions.
Detection of early changes in peripheral microcirculation in Sepsis to assist in-time treatment decisions.
